 |
|
|
| |
|
Comparison |
name |
Catalog # |
Specificity/Activity |
Type |
Brand |
Size |
Price |
|
|
[D-Arg0, Hyp3, D-Tic7, Oic8]-Bradykinin (Human, Rat, Mouse) |
009-17 |
|
|
phoenix pep |
200 μg |
RMB
973 |
|
|
[D-Arg0, Hyp3, Igl5, D-Igl7, Oic8, Des-Arg9]-Bradykinin (Human, Rat, Mouse) |
009-21 |
|
|
phoenix pep |
200 μg |
RMB
1804 |
|
|
[D-Arg0, Hyp3, Igl5, D-Igl7, Oic8]-Bradykinin (Human, Rat, Mouse) |
009-22 |
|
|
phoenix pep |
200 μg |
RMB
1804 |
|
|
[D-Arg0, Hyp3, Thi5, D-Phe7, Thi8]-Bradykinin (Human, Rat, Mouse) |
009-13 |
|
|
phoenix pep |
500 μg |
RMB
973 |
|
|
[D-Arg0, Hyp3, Thi5, D-Tic7, Oic8]-Bradykinin / HOE 140 (Human, Rat, Mouse) |
009-18 |
|
|
phoenix pep |
200 μg |
RMB
1448 |
|
|
[D-Arg1, D-Phe5, D-Trp7, D-Trp9, Leu11]-Substance P (Human, Rat, Mouse) |
061-19 |
|
|
phoenix pep |
500 μg |
RMB
1341 |
|
|
[D-Arg1, D-Pro2, D-Trp7, D-Trp9, Leu11]-Substance P (Human, Rat, Mouse) |
061-20 |
|
|
phoenix pep |
500 μg |
RMB
1341 |
|
|
[D-Arg1, D-Tyr5, D-Trp7, D-Trp9, Leu11]-Substance P (Human, Rat, Mouse) |
061-21 |
|
|
phoenix pep |
500 μg |
RMB
1982 |
|
|
[D-Arg1, D-Tyr5, D-Trp7, D-Trp9, Leu11]-Substance P (Human, Rat, Mouse) - I-125 Labeled |
T-061-21 |
|
|
phoenix pep |
10 μCi |
RMB
12843 |
|
|
[D-Arg14, D-Arg15]-MGF Peptide amide / C-terminal peptide of IGF-1 Ec amide |
033-34 |
|
|
phoenix pep |
100 μg |
RMB
1982 |
|
|
[D-Arg2]-Dermorphin (1-4) Tetrapeptide amide |
020-03 |
|
|
phoenix pep |
500 μg |
RMB
499 |
|
|
[D-Arg2]-Kyotrophin |
037-02 |
|
|
phoenix pep |
5 mg |
RMB
819 |
|
|
[D-Arg6, Trp7, Leu8, Des-Gly10]-LHRH ethylamide (Human, Rat, Mouse, Porcine) |
040-15 |
|
|
phoenix pep |
1 mg |
RMB
973 |
|
|
[D-Arg8]-ACTH (4-10) (Human) |
001-03 |
|
|
phoenix pep |
500 μg |
RMB
1448 |
|
|
[D-Arg8]-Inotocin |
065-53 |
|
|
phoenix pep |
100 μg |
RMB
2148 |
|
|
[D-Arg8]-Vasopressin (AVP) (Human, Rat, Mouse, Ovine, Canine) |
065-09 |
|
|
phoenix pep |
1 mg |
RMB
1519 |
|
|
[Dehydro-Pro2]-Orexin B (Rat, Mouse) |
003-39 |
|
|
phoenix pep |
500 μg |
RMB
3988 |
|
|
[Dehydro-Pro4, Dehydro-Pro5]-Orexin B (Human) |
003-38 |
|
|
phoenix pep |
500 μg |
RMB
3988 |
|
|
[dehydro-Pro5, dehydro-Pro8, dehydro-Pro13]-Neuropeptide Y (NPY) (Human, Rat, Mouse) |
049-30 |
|
|
phoenix pep |
200 μg |
RMB
2730 |
|
|
[Delta-Pro2, Delta-Pro5, Delta-Pro8, Delta-Pro13]-Neuropeptide Y (NPY) (Human, Rat, Mouse) |
049-29 |
|
|
phoenix pep |
200 μg |
RMB
2730 |
|
|
[Des-acetyl]-MSH, alpha (Human, Rat, Mouse) |
043-03 |
|
|
phoenix pep |
500 μg |
RMB
653 |
|
|
[Des-Arg10]-HOE 140 (Human, Rat, Mouse) |
009-27 |
|
|
phoenix pep |
200 μg |
RMB
1448 |
|
|
[Des-Arg10]-HOE I40 |
AS-22970 |
|
|
Anaspec |
1 mg |
Inquiry |
|
|
[Des-Arg9, Leu8]-Bradykinin (Human, Rat, Mouse) |
009-09 |
|
|
phoenix pep |
5 mg |
RMB
902 |
|
|
[Des-Arg9]-Bradykinin / Angiotensin I Converting Enzyme Inhibitor (Human, Rat, Mouse) |
009-03 |
|
|
phoenix pep |
5 mg |
RMB
570 |
|
|
|
|
|